đ° Full Story
U.S. regulators and the drug distributor Viatris Specialty LLC have announced a nationwide recall of a single lot of Xanax XR (alprazolam) extendedârelease tablets after the product failed dissolution specifications.
The recall covers 3 mg, 60âtablet bottles with lot number 8177156 and an expiration date of Feb. 28, 2027.
The lot was distributed in the United States between Aug. 27, 2024 and May 29, 2025; the tablets were manufactured in Ireland.
The Food and Drug Administration classified the action as a Class II recall, meaning use or exposure could cause temporary or medically reversible adverse health consequences.
Viatris initiated the recall on March 17 and the FDA posted notice in April; no adverse events have been reported to date.
Pharmacies have been asked to remove affected stock.
Health agencies advise patients with the specific bottles to consult their prescriber or pharmacist before making any changes to therapy, because abrupt discontinuation of benzodiazepines can be harmful.







đŹ Commentary